Paolo Serafini
Paolo Serafini
Verified email at
Cited by
Cited by
Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells
G Gallina, L Dolcetti, P Serafini, C De Santo, I Marigo, MP Colombo, ...
The Journal of clinical investigation 116 (10), 2777-2790, 2006
Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression
P Serafini, I Borrello, V Bronte
Seminars in cancer biology 16 (1), 53-65, 2006
Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function
P Serafini, K Meckel, M Kelso, K Noonan, J Califano, W Koch, L Dolcetti, ...
The Journal of experimental medicine 203 (12), 2691-2702, 2006
Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells
P Serafini, S Mgebroff, K Noonan, I Borrello
Cancer research 68 (13), 5439-5449, 2008
Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism
A Mazzoni, V Bronte, A Visintin, JH Spitzer, E Apolloni, P Serafini, ...
The Journal of Immunology 168 (2), 689-695, 2002
Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cells
I Marigo, L Dolcetti, P Serafini, P Zanovello, V Bronte
Immunological reviews 222 (1), 162-179, 2008
L-arginine metabolism in myeloid cells controls T-lymphocyte functions
V Bronte, P Serafini, A Mazzoni, DM Segal, P Zanovello
Trends in immunology 24 (6), 301-305, 2003
Identification of a CD11b+/Gr-1+/CD31+ myeloid progenitor capable of activating or suppressing CD8+T cells
V Bronte, E Apolloni, A Cabrelle, R Ronca, P Serafini, P Zamboni, ...
Blood, The Journal of the American Society of Hematology 96 (12), 3838-3846, 2000
IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice
V Bronte, P Serafini, C De Santo, I Marigo, V Tosello, A Mazzoni, ...
The Journal of Immunology 170 (1), 270-278, 2003
High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells
P Serafini, R Carbley, KA Noonan, G Tan, V Bronte, I Borrello
Cancer research 64 (17), 6337-6343, 2004
Derangement of immune responses by myeloid suppressor cells
P Serafini, C De Santo, I Marigo, S Cingarlini, L Dolcetti, G Gallina, ...
Cancer Immunology, Immunotherapy 53, 64-72, 2004
Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination
C De Santo, P Serafini, I Marigo, L Dolcetti, M Bolla, P Del Soldato, ...
Proceedings of the National Academy of Sciences 102 (11), 4185-4190, 2005
Tumor-induced immune dysfunctions caused by myeloid suppressor cells
V Bronte, P Serafini, E Apolloni, P Zanovello
Journal of immunotherapy 24 (6), 431-446, 2001
Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma
DT Weed, JL Vella, IM Reis, AC De la Fuente, C Gomez, Z Sargi, ...
Clinical cancer research 21 (1), 39-48, 2015
Aptamer-mediated blockade of IL4Rα triggers apoptosis of MDSCs and limits tumor progression
F Roth, AC De La Fuente, JL Vella, A Zoso, L Inverardi, P Serafini
Cancer research 72 (6), 1373-1383, 2012
Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes
E Apolloni, V Bronte, A Mazzoni, P Serafini, A Cabrelle, DM Segal, ...
The Journal of Immunology 165 (12), 6723-6730, 2000
Tadalafil augments tumor specific immunity in patients with head and neck squamous cell carcinoma
JA Califano, Z Khan, KA Noonan, L Rudraraju, Z Zhang, H Wang, ...
Clinical cancer research 21 (1), 30-38, 2015
Activated marrow-infiltrating lymphocytes effectively target plasma cells and their clonogenic precursors
K Noonan, W Matsui, P Serafini, R Carbley, G Tan, J Khalili, M Bonyhadi, ...
Cancer research 65 (5), 2026-2034, 2005
Human fibrocytic myeloid‐derived suppressor cells express IDO and promote tolerance via Treg‐cell expansion
A Zoso, EMC Mazza, S Bicciato, S Mandruzzato, V Bronte, P Serafini, ...
European journal of immunology 44 (11), 3307-3319, 2014
Peptide-conjugated PAMAM dendrimer as a universal DNA vaccine platform to target antigen-presenting cells
P Daftarian, AE Kaifer, W Li, BB Blomberg, D Frasca, F Roth, ...
Cancer research 71 (24), 7452-7462, 2011
The system can't perform the operation now. Try again later.
Articles 1–20